GI Innovation Inc. Logo

GI Innovation Inc.

Researches and develops protein-based drugs for immuno-oncology and immunology.

358570 | KO

Overview

Corporate Details

ISIN(s):
KR7358570000
LEI:
Country:
South Korea
Address:
서울특별시 송파구 송파대로 167, 서울특별시

Description

GI Innovation Inc. is a bio-venture company that researches and develops innovative protein-based drugs. The company utilizes its proprietary GI-SMART™ platform to create novel biologics, focusing on immuno-oncology and immunology-related diseases. Its development pipeline includes key candidates such as GI-101, an immuno-oncology treatment, and GI-301 for IgE-mediated allergic diseases. The company's approach is guided by its 'Science, Strategy, Speed' (3S) strategy, which integrates basic science with translational research to accelerate drug development.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-04-01 00:00
권리락 (무상증자)
Korean 3.5 KB
2025-03-31 00:00
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 10.6 KB
2025-03-31 00:00
정기주주총회결과
Korean 25.9 KB
2025-03-31 00:00
주식매수선택권부여에관한신고
Korean 16.0 KB
2025-03-28 00:00
[기재정정]주식매수선택권부여에관한신고
Korean 25.2 KB
2025-03-28 00:00
[기재정정]주식매수선택권부여에관한신고
Korean 20.6 KB
2025-03-27 00:00
증권발행실적보고서
Korean 69.7 KB
2025-03-27 00:00
증권발행결과(자율공시) (주주배정 유상증자)
Korean 7.5 KB
2025-03-24 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-03-24 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-03-21 00:00
유상증자또는주식관련사채등의청약결과(자율공시) (주주배정 유상증자)
Korean 9.6 KB
2025-03-21 00:00
감사보고서제출
Korean 18.8 KB
2025-03-21 00:00
사업보고서 (2024.12)
Korean 489.4 KB
2025-03-20 00:00
주식등의대량보유상황보고서(일반)
Korean 475.0 KB
2025-03-17 00:00
[기재정정]주주총회소집공고
Korean 254.8 KB

Automate Your Workflow. Get a real-time feed of all GI Innovation Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for GI Innovation Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for GI Innovation Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.